Eli Lilly (LLY) financials · Finance & Quant Society

Balance sheet (USD)	Q2 2026 ended Jun 30, 2026	Q1 2026 ended Mar 31, 2026	Q4 2025 ended Dec 31, 2025	Q3 2025 ended Sep 30, 2025	Q2 2025 ended Jun 30, 2025	Q1 2025 ended Mar 31, 2025	Q4 2024 ended Dec 31, 2024	Q3 2024 ended Sep 30, 2024
Cash and equivalents	8.95B	5.28B	7.27B	9.79B	3.38B	3.09B	3.27B	3.37B
Short-term investments				121.60M	170.10M	127.40M	154.80M	149.40M
Receivables	20.08B	18.43B	17.76B	16.11B	14.17B	12.04B	11.01B	10.29B
Inventory	16.79B	14.53B	13.74B	12.18B	11.01B	9.31B	7.59B	7.46B
Total current assets	64.67B	54.84B	55.63B	62.07B	49.85B	41.26B	32.74B	31.42B
Property, plant and equipment	29.29B	26.54B	24.68B	22.32B	20.53B	18.47B	17.10B	16.17B
Goodwill and intangibles	26.96B	13.50B	12.42B	12.34B	11.68B	11.78B	11.94B	12.31B
Total assets	142.28B	116.58B	112.48B	114.94B	100.92B	89.39B	78.72B	75.61B
Accounts payable	6.11B	5.03B	5.38B	4.26B	4.08B	3.44B	3.23B	2.89B
Total current liabilities	47.74B	36.63B	35.23B	40.14B	39.02B	30.07B	28.38B	24.67B
Long-term debt	47.86B	39.37B	40.87B	40.87B	34.18B	34.50B	28.53B	29.05B
Total liabilities	108.40B	85.38B	85.94B	91.14B	82.65B	73.62B	64.44B	61.37B
Retained earnings	31.89B	29.51B	24.47B	22.25B	17.38B	15.10B	13.54B	13.63B
Shareholders' equity	33.88B	31.20B	26.54B	23.79B	18.27B	15.76B	14.27B	14.24B
Total debt	54.91B	43.37B	42.50B	42.51B	39.90B	38.52B	37.98B	31.12B
Net debt	45.96B	38.09B	35.23B	32.71B	36.53B	35.42B	34.71B	27.75B

From Eli Lilly's 10-K and 10-Q filings with the SEC. Fourth quarters, and quarters where the company only reported year-to-date totals, are worked out by subtracting the earlier quarters. Fiscal years are the company's own, so they may not match the calendar. A blank cell means the company did not report that line. New to this? Read balance sheet or reading a 10-K.

Eli Lilly

Charts

Report a problem